Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum a... von Janjigian, Y.Y., Sanchez-Vega, F., Jonsson, P., Tuvy, Y., Bouvier, N., Riches, J., Kundra, R., Ku, G., Hechtman, J.F., Kelsen, D., Tang, L., Ilson, D., Vakiani, E., Stadler, Z., Callahan, M., Solit, D.B., Berger, M.F., Taylor, B.S., Schultz, N.

Volltext

Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer von Janjigian, Yelena Y, Sanchez-Vega, Francisco, Jonsson, Philip, Chatila, Walid K, Hechtman, Jaclyn F, Ku, Geoffrey Y, Riches, Jamie C, Tuvy, Yaelle, Kundra, Ritika, Bouvier, Nancy, Vakiani, Efsevia, Gao, Jianjiong, Heins, Zachary J, Gross, Benjamin E, Kelsen, David P, Zhang, Liying, Strong, Vivian E, Schattner, Mark, Gerdes, Hans, Coit, Daniel G, Bains, Manjit, Stadler, Zsofia K, Rusch, Valerie W, Jones, David R, Molena, Daniela, Shia, Jinru, Robson, Mark E, Capanu, Marinela, Middha, Sumit, Zehir, Ahmet, Hyman, David M, Scaltriti, Maurizio, Ladanyi, Marc, Rosen, Neal, Ilson, David H, Berger, Michael F, Tang, Laura, Taylor, Barry S, Solit, David B, Schultz, Nikolaus

Volltext

Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer von Greally, Megan, Chou, Joanne F, Chatila, Walid K, Margolis, Matthew, Capanu, Marinela, Hechtman, Jaclyn F, Tuvy, Yaelle, Kundra, Ritika, Daian, Foysal, Ladanyi, Marc, Kelsen, David P, Ilson, David H, Berger, Michael F, Tang, Laura H, Solit, David B, Diaz, Jr, Luis A, Schultz, Nikolaus, Janjigian, Yelena Y, Ku, Geoffrey Y

Volltext

EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2 -Amplified Esophagogastric Cancer von Sanchez-Vega, Francisco, Hechtman, Jaclyn F, Castel, Pau, Ku, Geoffrey Y, Tuvy, Yaelle, Won, Helen, Fong, Christopher J, Bouvier, Nancy, Nanjangud, Gouri J, Soong, Joanne, Vakiani, Efsevia, Schattner, Mark, Kelsen, David P, Lefkowitz, Robert A, Brown, Karen, Lacouture, Mario E, Capanu, Marinela, Mattar, Marissa, Qeriqi, Besnik, Cecchi, Fabiola, Tian, Yuan, Hembrough, Todd, Nagy, Rebecca J, Lanman, Richard B, Larson, Steven M, Pandit-Taskar, Neeta, Schöder, Heiko, Iacobuzio-Donahue, Christine A, Ilson, David H, Weber, Wolfgang A, Berger, Michael F, de Stanchina, Elisa, Taylor, Barry S, Lewis, Jason S, Solit, David B, Carrasquillo, Jorge A, Scaltriti, Maurizio, Schultz, Nikolaus, Janjigian, Yelena Y

Volltext

Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer von Mondaca, Sebastian, Margolis, Matthew, Sanchez-Vega, Francisco, Jonsson, Philip, Riches, Jamie C., Ku, Geoffrey Y., Hechtman, Jaclyn F., Tuvy, Yaelle, Berger, Michael F., Shah, Manish A., Kelsen, David P., Ilson, David H., Yu, Kenneth, Goldberg, Zoe, Epstein, Andrew S., Desai, Avni, Chung, Vincent, Chou, Joanne F., Capanu, Marinela, Solit, David B., Schultz, Nikolaus, Janjigian, Yelena Y.

Volltext

Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric Cancer von Won, Elizabeth, Basunia, Azfar, Chatila, Walid K, Hechtman, Jaclyn F, Chou, Joanne F, Ku, Geoffrey Y, Chalasani, Sree B, Boyar, Michelle S, Goldberg, Zoe, Desai, Avni M, Tuvy, Yaelle, Berger, Michael F, Tang, Laura, Kelsen, David P, Schattner, Mark, Ilson, David H, Capanu, Marinela, Solit, David B, Schultz, Nikolaus, Janjigian, Yelena Y

Volltext

Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer von Ku, Geoffrey Y, Kemel, Yelena, Maron, Steve B, Chou, Joanne F, Ravichandran, Vignesh, Shameer, Zarina, Maio, Anna, Won, Elizabeth S, Kelsen, David P, Ilson, David H, Capanu, Marinela, Strong, Vivian E, Molena, Daniela, Sihag, Smita, Jones, David R, Coit, Daniel G, Tuvy, Yaelle, Cowie, Kendall, Solit, David B, Schultz, Nikolaus, Hechtman, Jaclyn F, Offit, Kenneth, Joseph, Vijai, Mandelker, Diana, Janjigian, Yelena Y, Stadler, Zsofia K

Volltext